focus -WSS

focus

author：hotspot 2025-09-30 22:06:08 - browse：2981

Erik Tokat -- biotech JPM coverage from STAT — Eric Tokat is co-president of investment banking at Centerview Partners. Courtesy Centerview Partners

SAN FRANCISCO — Eric Tokat, biotech’s most prolific dealmaker, believes 2024 will be another strong year for acquisitions, driven by Big Pharma’s need to restock pipelines with medicines that can generate sales in the coming years.

That’s not idle speculation. It’s perhaps as close to a guarantee one can get in biotech. Last year, Tokat’s advisory firm, Centerview Partners, was involved in 19 of the 23 biotech transactions valued at $1 billion or more. Two more acquisitions of Centerview clients — Harpoon Therapeutics and Ambrx Biopharma — were announced Monday morning.

“I’m not sure if we’re going to have 23 deals or 25 deals, but I think it’s going to be a good year,” said Tokat, speaking to STAT over coffee on the sidelines of the J.P. Morgan Healthcare Conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Galapagos to make CAR

WSS

Ripples from Flovent's discontinuation is killing children with asthma

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

HHS suspends federal funding for EcoHealth Alliance

Medicare to pay more for cardiac rehab in hospital outpatient clinics

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

White House Covid adviser calls on docs to combat misinformation

Wikipedia

focus

hotspot

The high cost of giving birth even with insurance

The struggle to figure out which patients 'deserve' Wegovy

23andMe had bad news about my health. I wish a person had delivered it

'A game

Guidelines to prevent youth baseball injuries need more muscle

Patients, doctors press FTC to beef up hospital merger scrutiny

Anesthesiologist group: stop taking Ozempic before surgery

Ripples from Flovent's discontinuation is killing children with asthma

23andMe had bad news about my health. I wish a person had delivered it

Assistant physicians can help address the primary care shortage

explore

'A game

Obesity drug from Roche shows promise in early study

Abbott's new stent may help patients with peripheral artery disease

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

The White House hikes tariffs on plastic syringes made in China

Akili changes sales model for its ADHD video game treatment

knowledge

hotspot

hotspot

entertainment